Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03933631 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pilocarpine Use After Kahook Goniotomy

Study acronym: PAACK
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Suspended to Recruiting
    • Primary completion date: Dec 2026 to Jun 2028
    • Study completion date: Dec 2026 to Dec 2028
    • Site details revised at 2 of 2 sites
    v11
  2. Primary and study completion dates: Dec 2025 to Dec 2026v10 Show 4 more changesShow less
    • Sponsor's reason: IRB approval has elapsed as of 7/11/2024. All study activities have ceased pending further planning. to IRB approval lapsed 7/11/2025. All ongoing study activities have ceased pending recertification by the IRB. Primary Completion and Study…
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: 2 to 5
    • Study description revised
  3. Trial status: Recruiting to Suspended Sponsor's reason: IRB approval has elapsed as of 7/11/2024. All study activities have ceased pending further planning.
    • Site details revised at 2 of 2 sites
    v9
  4. Trial status: Suspended to Recruiting
    • Primary and study completion dates: Dec 2024 to Dec 2025
    • Site details revised at 2 of 2 sites
    v8
  5. Trial status: Enrolling by Invitation to Suspended Sponsor's reason: IRB approval has elapsedv7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary and study completion dates: Dec 2022 to Dec 2024v6
  2. 2 versions Re-verified since Dec 11, 2020, no change to tracked fieldsv4-v5
  3. Trial status: Recruiting to Enrolling by Invitation
    • Site details revised at 2 of 2 sites
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of May 2019 to May 1, 2019
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.
Trial Details
NCT Number NCT03933631
Lead Sponsor Montefiore Medical Center
Conditions
(from sponsor)		 Glaucoma
Related terms Cataract, Glaucoma
Enrollment 142 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov